On January 20, 2023, Voyageur Pharmaceuticals Ltd. closed the transaction. The company issued 14,570,764 units at a price of CAD 0.07 per unit for the gross proceeds of CAD 1,019,954 in its final tranche bringing the total number of 17,142,133 units for the total gross proceeds of CAD 1,199,949. The TSX Venture Exchange has accepted for filing documentation with respect to anon-brokered private placement.

The transaction included participation from 54 placees including pro group involvement of ne placee for 300,000.